Tenders Are Invited For Oseltamivir Capsules 75 Mg, Ascorbic Acid Solution For Injection, 50 Mg/Ml In 2 Ml, Diphenhydramine, Solution For Injection, 10 Mg/Ml, In 1 Ml, Drotaverine Solution For Injection 20 Mg/Ml, 2 Ml In An Ampoule, Diclofenac Solution For Injection 25 Mg/Ml, Papaverine, Solution For Injection, 20 Mg/Ml, 2 Ml Each, Metoclopramide, Solution For Injection, 5 Mg/Ml, 2 Ml Each , Loratadine Tablets 10 Mg, Human Insulin (Combination: 30% Short-Acting; 70% Medium-Acting), Suspension For Injection, 100 U/Ml, Cartridge, 3 Ml Each, Chlorhexidine, Solution For External Use 0, 05% Per 100 Ml, No. 1, Meropenem, Powder For Injection, 1 G Each, Salts For Oral Rehydration, Powder For Oral Solution, 4.4 G Each, Troxerutin In Combination, Solution For Injection, 150 Mg/ 1.5 Mg/ 3 Ml, Quercetin Lyophilisate For Solution For Injection, 0.5 G, Enoxaparin Sodium, Solution For Injection, 10,000 Anti-Xa Iu/Ml, 0.4 Ml

Tender Detail

83233564
UA-2024-07-19-001926-a
Self-Funded
Tenders Are Invited For Oseltamivir Capsules 75 Mg, Ascorbic Acid Solution For Injection, 50 Mg/Ml In 2 Ml, Diphenhydramine, Solution For Injection, 10 Mg/Ml, In 1 Ml, Drotaverine Solution For Injection 20 Mg/Ml, 2 Ml In An Ampoule, Diclofenac Solution For Injection 25 Mg/Ml, Papaverine, Solution For Injection, 20 Mg/Ml, 2 Ml Each, Metoclopramide, Solution For Injection, 5 Mg/Ml, 2 Ml Each , Loratadine Tablets 10 Mg, Human Insulin (Combination: 30% Short-Acting; 70% Medium-Acting), Suspension For Injection, 100 U/Ml, Cartridge, 3 Ml Each, Chlorhexidine, Solution For External Use 0, 05% Per 100 Ml, No. 1, Meropenem, Powder For Injection, 1 G Each, Salts For Oral Rehydration, Powder For Oral Solution, 4.4 G Each, Troxerutin In Combination, Solution For Injection, 150 Mg/ 1.5 Mg/ 3 Ml, Quercetin Lyophilisate For Solution For Injection, 0.5 G, Enoxaparin Sodium, Solution For Injection, 10,000 Anti-Xa Iu/Ml, 0.4 Ml
ICB
Eastern Europe
Commonwealth of Independent States, CIS
24-07-2024

Work Detail

Oseltamivir Capsules 75Mg, Ascorbic Acid Solution For Injection, 50Mg/Ml 2Ml, Diphenhydramine, Solution For Injection, 10Mg/Ml, 1Ml, Drotaverine Solution For Injection 20Mg/Ml, 2Ml In Ampoule, Diclofenac Solution For Injection 25 Mg/Ml, Papaverine, Solution For Injection, 20 Mg/Ml, 2 Ml Each, Metoclopramide, Solution For Injection, 5 Mg/Ml, 2 Ml Each, Loratadine Tablets 10 Mg Each, Human Insulin ( Combination: 30% Short-Acting; 70% Medium-Acting), Suspension For Injection, 100 Units/Ml, Cartridge, 3 Ml, Chlorhexidine, Solution For External Use 0.05%, 100 Ml, Meropenem , Powder For Injection, 1 G Each, Salts For Oral Rehydration, Powder For Oral Solution, 4.4 G Each, Troxerutin In Combination, Solution For Injection, 150 Mg/ 1.5 Mg/ 3 Ml, Quercetin Lyophilisate For Solution For Injection P 0.5 G, Enoxaparin Sodium, Solution For Injection, 10000 Anti-Ha Mo/Ml, Each 0.4 Ml

Key Value

Tender Value
8,40,000 - UAH

Attachment

FileName File Description
Global Tender Document Tender Notice
Attachments
Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2024 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail